This inventor holds 2 USPTO granted patents. Top assignee: Agilvax Inc.. Active years: 2020-2021.
Location History:
- Alburuerque, NM (US) (2020)
- Albuquerque, NM (US) (2021)
Company Filing History:
Years Active: 2020-2021
Title: John P O'Rourke: Innovator in Cancer Immunotherapy
Introduction
John P O'Rourke is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of cancer immunotherapy, particularly through his innovative work on xCT peptides. With a total of 2 patents, O'Rourke is dedicated to advancing medical science and improving treatment options for cancer patients.
Latest Patents
O'Rourke's latest patents focus on compositions and methods related to xCT peptides. Certain embodiments of these patents are directed to compositions that induce an immune response against xCT, specifically targeting cancer stem cells that express xCT. This innovative approach has the potential to enhance the effectiveness of cancer treatments and provide new avenues for research.
Career Highlights
Throughout his career, John P O'Rourke has been associated with Agilvax Inc., a company that specializes in developing immunotherapies. His work at Agilvax has allowed him to collaborate with other talented professionals in the field, furthering the impact of his inventions.
Collaborations
Some of O'Rourke's notable coworkers include Federica Cavallo and Stefania Lanzardo. Their collaborative efforts contribute to the innovative environment at Agilvax Inc., fostering advancements in cancer treatment.
Conclusion
John P O'Rourke is a pioneering inventor whose work in cancer immunotherapy is making a significant impact. His patents and collaborations reflect his commitment to improving healthcare through innovation.